...
首页> 外文期刊>American Journal of Cancer Research >PAQR3: a novel tumor suppressor gene
【24h】

PAQR3: a novel tumor suppressor gene

机译:PAQR3:一种新型的肿瘤抑制基因

获取原文
   

获取外文期刊封面封底 >>

       

摘要

PAQR3, also known as RKTG (Raf kinase trapping to Golgi), is a member of the progestin and adipoQ receptor (PAQR) family. The role of PAQR3 as a tumor suppressor has recently been established in different types of human cancer in which PAQR3 exerts its biological function through negative regulation of the oncogenic Raf/MEK/ERK signaling. Multiple studies have found that PAQR3 downregulation frequently occurs in human cancers and is very often associated with tumor progression and shortened patients’ survival. Moreover, restoring the expression of PAQR3 could induce apoptosis and inhibit proliferation and invasiveness of cancer cells. Downregulation of PAQR3 by oncogenic microRNAs has also been reported. In this review, we summarized current knowledge concerning the role of PAQR3 in tumor development. To our knowledge, this is the first review on the role of this novel tumor suppressor.
机译:PAQR3,也称为RKTG(捕获到高尔基体的Raf激酶),是孕激素和adipoQ受体(PAQR)家族的成员。最近已经在不同类型的人类癌症中确立了PAQR3作为抑癌药的作用,其中PAQR3通过对致癌Raf / MEK / ERK信号的负调控来发挥其生物学功能。多项研究发现,PAQR3的下调在人类癌症中经常发生,并且经常与肿瘤进展和患者生存期缩短有关。此外,恢复PAQR3的表达可以诱导癌细胞凋亡并抑制癌细胞的增殖和侵袭性。也已经报道了致癌的microRNA下调PAQR3。在这篇综述中,我们总结了有关PAQR3在肿瘤发展中作用的最新知识。据我们所知,这是关于这种新型肿瘤抑制剂作用的首次综述。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号